Skip to content
2000
Volume 20, Issue 1
  • ISSN: 1872-2083
  • E-ISSN: 2212-4012

Abstract

A significant portion of the population in low-income countries relies on medicinal plants for healthcare. Fava d'anta is an important species in Brazil due to its bioactive compounds like quercetin and rutin. These compounds have various pharmaceutical applications, but the sustainability of their exploitation is challenged by overharvesting, necessitating sustainable management practices and further biotechnological advancements. The study conducted a comprehensive review of patents and their applications in various pharmacological activities, which are crucial for the development of new medicines and formulations. Patents were searched in four specialized patent databases: The United States Patent and Trademark Office, the World Intellectual Property Organization (WIPO), Espacenet and the National Institute of Industrial Property (INPI). A total of 109 patents were identified through document collection, with 26 patents meeting the inclusion criteria. The analysis revealed a global concentration of innovation in regions like Europe and the United States. Fava d'anta has demonstrated a wide range of therapeutic properties, including antioxidant and anti-inflammatory effects, largely attributed to polyphenols. These bioactive components have shown potential in diverse applications, from nutraceuticals to cosmetics. Patent registrations highlight the significant potential of species for phytoproducts, particularly due to compounds like quercetin and rutin, but further studies are needed to explore their mechanisms of action and enhance technological applications, especially in cosmetics.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/biot/10.2174/0118722083349741250325035323
2025-04-10
2025-10-21

  • From This Site

    /content/journals/biot/10.2174/0118722083349741250325035323
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AstutikS. PretzschJ. KimengsiN.J. Asian medicinal plants’ production and utilization potentials: A review.Sustainability (Basel)20191119548310.3390/su11195483
     [Google Scholar]
  2. TuashaN. PetrosB. AsfawZ. Medicinal plants used by traditional healers to treat malignancies and other human ailments in Dalle District, Sidama Zone, Ethiopia.J. Ethnobiol. Ethnomed.20181411510.1186/s13002‑018‑0213‑z 29444684
     [Google Scholar]
  3. MajoloF. Oliveira Becker Delwingd.L.K. MarmittD.J. Bustamante-FilhoI.C. GoettertM.I. Medicinal plants and bioactive natural compounds for cancer treatment: Important advances for drug discovery.Phytochem. Lett.20193119620710.1016/j.phytol.2019.04.003
     [Google Scholar]
  4. DeheleanC.A. MarcoviciI. SoicaC. Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy.Molecules2021264110910.3390/molecules26041109 33669817
     [Google Scholar]
  5. MarquesL.G.A. NetoV.J.B. SalesS.L.A. O impacto da bioprospecção para o descobrimento de novas moléculas terapêuticas.Revista Fitos202216Suppl. 229331410.32712/2446‑4775.2022.1313
     [Google Scholar]
  6. UrsulinoM.M. AlvesE.U. AraújoP.C. AlvesM.M. RibeiroT.S. SilvaR.S. Superação de dormência e vigor em sementes de fava-d’Anta (Dimorphandra gardneriana Tulasne).Cienc. Florest.201929110511510.5902/1980509810460
     [Google Scholar]
  7. Alcântara dMS, Lucena dRFP, Cruz dDD. Toward sustainable production chain by SWOT-AHP analysis: A case study of fava d’anta (Dimorphandra gardneriana Tulasne) production chain.Environ. Dev. Sustain.20222422056207810.1007/s10668‑021‑01520‑y
     [Google Scholar]
  8. RochaV.D. Dal’SassoT.C.S. WilliamsC.C.V. SimonM.F. BuenoM.L. OliveiraL.O. From forest to savanna and back to forest: Evolutionary history of the genus Dimorphandra (Fabaceae).J. Plant Res.2024137337739310.1007/s10265‑024‑01523‑6 38369599
     [Google Scholar]
  9. CostaK.P. MeiraM.R. RochaS.L. FernandesT.O.M. MartinsE.R. Yield and diametric structure of Dimorphandra mollis benth.Pesqui. Agropecu. Trop.2021
     [Google Scholar]
  10. RibeiroD.A. OliveiraL.G.S. MacêdoD.G. Promising medicinal plants for bioprospection in a Cerrado area of Chapada do Araripe, Northeastern Brazil.J. Ethnopharmacol.201415531522153310.1016/j.jep.2014.07.042 25086410
     [Google Scholar]
  11. NunesJ.D. NeryP.S. FigueiredoL.S. CostaC.A. MartinsE.R. O extrativismo da fava d’anta (Dimorphandra mollis Benth.) na região do Norte de Minas Gerais.Revista Brasileira de Plantas Medicinais2012
     [Google Scholar]
  12. Alcântarad.M.S. DuarteA.E. BoligonA.A. Effects of different levels of exploration on the ecological processes of Dimorphandra gardneriana, a tropical savanna tree.Environ. Monit. Assess.2020192637810.1007/s10661‑020‑08344‑932424709
     [Google Scholar]
  13. G. M. CostaJ. Dimorphandra gardneriana Tulasne (fava d’anta) - Uma abordagem etnobotânica e riscos de extinção.Revista Da Biologia2012910.7594/revbio.09.01.02
     [Google Scholar]
  14. XinX. ZhangM. LiX. LaiF. ZhaoG. Biocatalytic synthesis of acylated derivatives of troxerutin: Their bioavailability and antioxidant properties in vitro.Microb. Cell Fact.201817113010.1186/s12934‑018‑0976‑x 30134913
     [Google Scholar]
  15. MecenasA.S. MalafaiaA.C.R. SangenitoL.S. Rutin derivatives obtained by transesterification reactions catalyzed by Novozym 435: Antioxidant properties and absence of toxicity in mammalian cells.PLoS One2018139e020315910.1371/journal.pone.0203159 30231045
     [Google Scholar]
  16. KapešováJ. PetráskováL. MarkošováK. Bioproduction of quercetin and rutinose catalyzed by rutinosidase: Novel concept of “solid state biocatalysis.”.Int. J. Mol. Sci.2019205111210.3390/ijms20051112 30841519
     [Google Scholar]
  17. AraújoK.C.F. M B CostadEM. PaziniF. ValadaresMC. OliveiradV. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products.Food Chem. Toxicol.201351939610.1016/j.fct.2012.09.015 23000251
     [Google Scholar]
  18. FengD. FangZ. ZhangP. The melanin inhibitory effect of plants and phytochemicals: A systematic review.Phytomedicine202210715444910.1016/j.phymed.2022.154449 36126406
     [Google Scholar]
  19. SáMK SoaresLI LeãoSdMV Technology prospection of ora-pro-nóbis (Pereskia aculeata Mill.): A non-conventional food plant.Recent Pat. Biotechnol.202418214415110.2174/1872208317666230502101802 37138429
     [Google Scholar]
  20. LealPAEB LavordÉM BarbosaMdJ Pharmacological activities of the genus Passiflora (Passifloraceae): A patent review.Curr. Top. Med. Chem.202222282315232810.2174/1568026622666220819160923 35986522
     [Google Scholar]
  21. ValadasLAR Oliveira-FilhodRD OliveiradMBL Products of dental use containing copaiba oil-resin: Technological prospecting based on patents.Recent Pat. Biotechnol.2020141334010.2174/1872208313666190719153114 31333133
     [Google Scholar]
  22. ValadasLAR FilhoOdRD LotifMAL Development and innovation on dental products in argentina: A technological prospecting based on patents.Recent Pat. Biotechnol.202115131110.2174/1872208314999201210222828 33305714
     [Google Scholar]
  23. TenniB. MoirH.V.J. TownsendB. What is the impact of intellectual property rules on access to medicines? A systematic review.Global. Health20221814010.1186/s12992‑022‑00826‑4 35428250
     [Google Scholar]
  24. LaffonM. DomontJ. HanoC. LanoueA. Giglioli-Guivarc’hN. Unlocking specialized metabolism in medicinal plant biotechnology through plant–microbiome interactions.Curr. Opin. Plant Biol.20248210262010.1016/j.pbi.2024.102620 39241282
     [Google Scholar]
  25. GuoM. LvH. ChenH. Strategies on biosynthesis and production of bioactive compounds in medicinal plants.Chin. Herb. Med.2024161132610.1016/j.chmed.2023.01.007 38375043
     [Google Scholar]
  26. KowalczykT. WieczfinskaJ. SkałaE. ŚliwińskiT. SitarekP. Transgenesis as a tool for the efficient production of selected secondary metabolites from in vitro plant cultures.Plants20209213210.3390/plants9020132 31973076
     [Google Scholar]
  27. BragaF.C. Paving new roads towards biodiversity-based drug development in brazil: Lessons from the past and future perspectives.Rev. Bras. Farmacogn.202131550551810.1007/s43450‑021‑00181‑2 34548709
     [Google Scholar]
  28. DutraR.C. CamposM.M. SantosA.R.S. CalixtoJ.B. Medicinal plants in brazil: Pharmacological studies, drug discovery, challenges and perspectives.Pharmacol. Res.201611242910.1016/j.phrs.2016.01.021 26812486
     [Google Scholar]
  29. MacFarlaneA. Russell-RoseT. ShokranehF. Search strategy formulation for systematic reviews: Issues, challenges and opportunities.Intell Sys Appl20221520009110.1016/j.iswa.2022.200091
     [Google Scholar]
  30. FurtadoCdJHJr ValadasRLA MendonçaKS Propolis and its dental applications: A technological prospection.Recent Pat. Biotechnol.201812428829610.2174/2211550107666180815114855 30156167
     [Google Scholar]
  31. AkkariA.C.S. MunhozI.P. TomiokaJ. SantosD.N.M.B.F. SantosD.R.F. Technological innovation in the pharmaceutical industry: Differences between Europe, the USA and pharmaceutical emerging countries.Manag Prod201616
     [Google Scholar]
  32. LimaJ. DallariS. The global strategy on public health, innovation and intellectual property: Establishment of a priority order for research and development needs in Brazil.Health Soc2020292e18116210.1590/S0104‑12902020181162
     [Google Scholar]
  33. HashemiB. ShiriF. ŠvecF. NovákováL. Green solvents and approaches recently applied for extraction of natural bioactive compounds.Trends Analyt. Chem.202215711673210.1016/j.trac.2022.116732
     [Google Scholar]
  34. LeiteD.O.D. CamiloC.J. NonatoC.F.A. Evaluation of solvents extractors of rutin from Dimorphandra gardneriana (leguminosae) and in vitro antioxidant tests.Brazil J Devel202064168021681810.34117/bjdv6n4‑011
     [Google Scholar]
  35. LeeJ. KwonK.H. Sustainable changes in beauty market trends focused on the perspective of safety in the post‐coronavirus disease‐19 period.J. Cosmet. Dermatol.20222172700270710.1111/jocd.14493 35397181
     [Google Scholar]
  36. DiniI. LaneriS. The new challenge of green cosmetics: Natural food ingredients for cosmetic formulations.Molecules20212613392110.3390/molecules26133921 34206931
     [Google Scholar]
  37. Faria-SilvaC. AscensoA. CostaA.M. Feeding the skin: A new trend in food and cosmetics convergence.Trends Food Sci. Technol.202095213210.1016/j.tifs.2019.11.015
     [Google Scholar]
  38. LinkA.N. SiegelD.S. FleetV.D.D. Public science and public innovation: Assessing the relationship between patenting at U.S. National Laboratories and the Bayh-Dole Act.Res. Policy20114081094109910.1016/j.respol.2011.05.011
     [Google Scholar]
  39. HeinrichM. SharmaS.K. SuetterleU. BhamraS.K. Herbal medicine use in the UK and Germany and pharmacy practice - A commentary.Res. Social Adm. Pharm.202319353554010.1016/j.sapharm.2022.11.006 36494278
     [Google Scholar]
  40. FerreiraR.B. ParreiraM.R. NaboutJ.C. Is there concordance between science and technology in natural science? mapping the relationship among number of papers and patents from research on cerrado plants.World Pat. Inf.20226910210810.1016/j.wpi.2022.102108
     [Google Scholar]
  41. FolgosiM. ValverdeA.L. FiauxS.B. MourãoS.C. LealR.H. CerqueiraA.M.F. New law of Brazilian biodiversity: Legal aspects and impact in the field of biotechnology.Acad Bras Cienc202193suppl 4e20210413
     [Google Scholar]
  42. YuX. ZhangB. Obtaining advantages from technology revolution: A patent roadmap for competition analysis and strategy planning.Technol. Forecast. Soc. Change201914527328310.1016/j.techfore.2017.10.008
     [Google Scholar]
  43. JesusC.S. CardosoD.O. SouzaC.G. Motivational factors for patenting: A study of the Brazilian researchers profile.World Pat. Inf.20237510224110.1016/j.wpi.2023.102241
     [Google Scholar]
  44. PereiraF.D.C. CostaH.G. PereiraV. Stimulating and inhibiting factors of patent filing with Brazilian universities.Int. J. Entrep. Innov. Manag.201923326128010.1504/IJEIM.2019.099844
     [Google Scholar]
  45. SouzaR.K.D. SilvaM.A.P. MenezesI.R.A. RibeiroD.A. BezerraL.R. SouzaM.M.A. Ethnopharmacology of medicinal plants of Carrasco, Northeastern Brazil.J. Ethnopharmacol.20141579910410.1016/j.jep.2014.09.001 25240589
     [Google Scholar]
  46. MigliatoK.F. ChorilliM. ScarpaM.V. Verificação da atividade antibacteriana de sabonete líquido contendo extrato glicólico de Dimorphandra mollis Benth.Rev. Cienc. Farm. Basica Apl.200930216
     [Google Scholar]
  47. OliveiraA.F. JuniorC.L.M. LimaA.S. Anthelmintic activity of plant extracts from Brazilian savanna.Vet. Parasitol.201723612112710.1016/j.vetpar.2017.02.005 28288755
     [Google Scholar]
  48. HubingerS.Z. SalgadoH.R.N. MoreiraR.R.D. Physical, physicochemical, chemical and microbiological controls on the fruits of Dimorphandra mollis Benth., Fabaceae.Brazil J Pharma20091931610.1590/S0102‑695X2009000500007
     [Google Scholar]
  49. LandimL.P. FeitozaG.S. CostadJGM. Development and validation of a HPLC method for the quantification of three flavonoids in a crude extract of Dimorphandra gardneriana.Brazil J Pharma20132315864
     [Google Scholar]
  50. SilvadGS. BaiaAM. HopkinsMJG. Mansano V deF. Gonçalves A dosS. Clarifying the taxonomic and geographic relationships between Dimorphandra gardneriana Tul and Dimorphandra mollis Benth in the Brazilian cerrado 38o Northeastern Botany Meeting.SoftalizeSaint Louis20241
     [Google Scholar]
  51. Septembre-MalaterreA. BoumendjelA. SeteyenA.L.S. Focus on the high therapeutic potentials of quercetin and its derivatives.Phytomed. Plus20222110022010.1016/j.phyplu.2022.100220 35403087
     [Google Scholar]
  52. ValentováK. VrbaJ. BancířováM. UlrichováJ. KřenV. Isoquercitrin: Pharmacology, toxicology, and metabolism.Food Chem. Toxicol.20146826728210.1016/j.fct.2014.03.018 24680690
     [Google Scholar]
  53. MagarR.T. SohngJ.K. A review on structure, modifications and structure-activity relation of quercetin and its derivatives.J. Microbiol. Biotechnol.2020301112010.4014/jmb.1907.07003 31752056
     [Google Scholar]
  54. AlizadehS.R. EbrahimzadehM.A. O ‐Glycoside quercetin derivatives: Biological activities, mechanisms of action, and structure–activity relationship for drug design, a review.Phytother. Res.202236277880710.1002/ptr.7352 34964515
     [Google Scholar]
  55. CarmonaF. PereiraA.M.S. Herbal medicines: Old and new concepts, truths and misunderstandings.Brazil J Pharma2013232379385
     [Google Scholar]
  56. FidelesLS MirandadJAL MartinsCS Role of rutin in 5-fluorouracil-induced intestinal mucositis: Prevention of histological damage and reduction of inflammation and oxidative stress.Molecules20202512278610.3390/molecules25122786 32560278
     [Google Scholar]
  57. RechenchoskiD.Z. SamensariN.L. Faccin-GalhardiL.C. The combination of Dimorphandra gardneriana galactomannan and mangiferin inhibits herpes simplex and poliovirus.Curr. Pharm. Biotechnol.201920321522110.2174/1389201020666190307130431 30848197
     [Google Scholar]
  58. PetacciF. FreitasS.S. BrunettiI.L. KhalilN.M. Inhibition of peroxidase activity and scavenging of reactive oxygen species by astilbin isolated from Dimorphandra mollis (Fabaceae, Caesalpinioideae).Biol. Res.2010431637410.4067/S0716‑97602010000100008 21157633
     [Google Scholar]
  59. HidalgoM. Sánchez-MorenoC. Pascual-TeresadS. Flavonoid–flavonoid interaction and its effect on their antioxidant activity.Food Chem.2010121369169610.1016/j.foodchem.2009.12.097
     [Google Scholar]
  60. MitraS. TareqA.M. DasR. Polyphenols: A first evidence in the synergism and bioactivities.Food Rev. Int.20233974419444110.1080/87559129.2022.2026376
     [Google Scholar]
  61. ZouH. YeH. KamarajR. ZhangT. ZhangJ. PavekP. A review on pharmacological activities and synergistic effect of quercetin with small molecule agents.Phytomedicine20219215373610.1016/j.phymed.2021.153736 34560520
     [Google Scholar]
  62. GaneshpurkarA. SalujaA.K. The pharmacological potential of rutin.Saudi Pharm. J.201725214916410.1016/j.jsps.2016.04.025 28344465
     [Google Scholar]
  63. FéresC.A.O. MadalossoR.C. RochaO.A. Acute and chronic toxicological studies of Dimorphandra mollis in experimental animals.J. Ethnopharmacol.2006108345045610.1016/j.jep.2006.06.002 16872769
     [Google Scholar]
  64. HammarfeltB. Linking science to technology: The “patent paper citation” and the rise of patentometrics in the 1980s.J. Doc.20217761413142910.1108/JD‑12‑2020‑0218
     [Google Scholar]
  65. MalhabL.J.B. Saber-AyadM.M. Al-HakmR. Chronic inflammation and cancer: The role of endothelial dysfunction and vascular inflammation.Curr. Pharm. Des.202127182156216910.2174/1381612827666210303143442 33655853
     [Google Scholar]
  66. McGurranH. GlennJ. MaderoE. BottN. Risk reduction and prevention of Alzheimer’s disease: Biological mechanisms of diet.Curr. Alzheimer Res.202017540742710.2174/1567205017666200624200651 32579499
     [Google Scholar]
  67. ShibuM.A. BharathM. VelmuruganB.K. Regulating inflammation associated ferroptosis - A treatment strategy for parkinson disease.Curr. Med. Chem.202128336895691410.2174/0929867328666210419125032 33874863
     [Google Scholar]
  68. KoutsaliarisI.K. MoschonasI.C. PechlivaniL.M. TsoukaA.N. TselepisA.D. Inflammation, oxidative stress, vascular aging and atherosclerotic ischemic stroke.Curr. Med. Chem.202229345496550910.2174/0929867328666210921161711 34547993
     [Google Scholar]
  69. MangoniA.A. TommasiS. SotgiaS. Asymmetric dimethylarginine: A key player in the pathophysiology of endothelial dysfunction, vascular inflammation and atherosclerosis in rheumatoid arthritis?Curr. Pharm. Des.202127182131214010.2174/1381612827666210106144247 33413061
     [Google Scholar]
  70. StefanoD.A. ManiscalcoM. BalbiB. RicciardoloF.L.M. Oxidative and nitrosative stress in the pathogenesis of obstructive lung diseases of increasing severity.Curr. Med. Chem.202027427149715810.2174/0929867327666200604165451 32496983
     [Google Scholar]
  71. MirR.H. ShahA.J. Mohi-Ud-DinR. Natural anti-inflammatory compounds as drug candidates in alzheimers disease.Curr. Med. Chem.202128234799482510.2174/1875533XMTA4aNzUBx 32744957
     [Google Scholar]
  72. HanoC. TungmunnithumD. Plant polyphenols, more than just simple natural antioxidants: Oxidative stress, aging and age-related diseases.Medicines2020752610.3390/medicines7050026 32397520
     [Google Scholar]
  73. SobhaniM. FarzaeiM.H. KianiS. KhodarahmiR. Immunomodulatory; anti-inflammatory/antioxidant effects of polyphenols: A comparative review on the parental compounds and their metabolites.Food Rev. Int.202137875981110.1080/87559129.2020.1717523
     [Google Scholar]
  74. FastD.J. PattersonJ. RajgopalA. Antioxidant dietary supplement and related method.Patent US201401475262013
  75. Michel-SalaunF. ConeggoN. Combination of natural antioxidants.Patent WO20170850992016
  76. MastaloudisA. WoodS. BargerJ.L. Oral formulations for promoting cellular purification.Patent WO20121257722012
  77. JonesJ.A. MontesinosC.A. Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress.Patent WO20131520552013
  78. PattL.M. Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto.Patent WO20040144132004
  79. LubranoC. MilesiS. Preparing flavonoid glycoside oligomer comprises solubilizing flavonoid glycoside in mixture comprising glycerin, ethanol and aqueous solution to obtain solution having flavonoid and polymerizing solubilized flavonoid glycoside by laccase.Patent FR2944794A12009
  80. SamaritaniG. CastelliS. Formulations for use in the treatment of endometriosis and disorders therewith associated.Patent EP33387692018
  81. ChaichianS. NikfarB. BidgoliA.S. MoazzamiB. The role of quercetin for the treatment of endometriosis and endometrial cancer: A comprehensive review.Curr. Med. Chem.2023311610.2174/0109298673269733230921092509 37861023
     [Google Scholar]
  82. MenonG.R. FastD.J. Anti-allergy composition and related method.WO Patent 20050749592005
  83. StudinJ.R. Composition and method for treatment of bruising.WO Patent 2010059554A22010
  84. MuvhulawaN. DludlaP.V. ZiqubuK. Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature.Pharmacol. Res.202217810616310.1016/j.phrs.2022.106163 35257898
     [Google Scholar]
  85. KaruppagounderV. ArumugamS. ThandavarayanR.A. SreedharR. GiridharanV.V. WatanabeK. Molecular targets of quercetin with anti-inflammatory properties in atopic dermatitis.Drug Discov. Today201621463263910.1016/j.drudis.2016.02.011 26905599
     [Google Scholar]
  86. CherubimLdDJ. MartinsBCV. FariñaOL. Silva de LuccadRA. Polyphenols as natural antioxidants in cosmetics applications.J. Cosmet. Dermatol.2020191333710.1111/jocd.13093 31389656
     [Google Scholar]
  87. BharadvajaN. GautamS. SinghH. Natural polyphenols: A promising bioactive compounds for skin care and cosmetics.Mol. Biol. Rep.20235021817182810.1007/s11033‑022‑08156‑9 36494596
     [Google Scholar]
  88. ClausEvJ. Composition with improved SPF and UVA photoprotection.WO Patent 2024027928A12024
  89. ClausEvJ. Composition with improved water resistance.EP Patent 0434179A12024
  90. ClausEvJ. Composition comprising a UV-filter stabilizer.WO Patent 20240285152024
  91. ClausEvJ. Compositions comprising an antimicrobial boosting agent.WO Patent 20240279302024
  92. ClausEvJ. Odor and colorant stabilized compositions.WO Patent 2024027931A12022
  93. CefaliL.C. AtaideJ.A. FernandesA.R. Evaluation of in vitro solar protection factor (SPF), antioxidant activity, and cell viability of mixed vegetable extracts from Dimorphandra mollis Benth., Ginkgo biloba L., Ruta graveolens L., and Vitis vinifera L.Plants201981145310.3390/plants8110453 31717792
     [Google Scholar]
  94. JacobM.T. Cosmetic compositions comprising Pilocarpus jaborandi, Aloe vera extracts.WO Patent 19960166671996
  95. CucioD.M. Preparação cosmética para uso capilar.BR Patent PI1000582A22010
  96. DubeyS.K. DeyA. SinghviG. PandeyM.M. SinghV. KesharwaniP. Emerging trends of nanotechnology in advanced cosmetics.Colloids Surf. B Biointerfaces202221411244010.1016/j.colsurfb.2022.112440 35344873
     [Google Scholar]
  97. GuptaV. MohapatraS. MishraH. Nanotechnology in cosmetics and cosmeceuticals—A review of latest advancements.Gels20228317310.3390/gels8030173 35323286
     [Google Scholar]
  98. WadherK. TrivediR. WankhedeN. KaleM. UmekarM. 3D printing in pharmaceuticals: An emerging technology full of challenges.Ann. Pharm. Fr.202179210711810.1016/j.pharma.2020.08.007 32853575
     [Google Scholar]
  99. PolatE. KangK. Natural photosensitizers in antimicrobial photodynamic therapy.Biomedicines20219658410.3390/biomedicines9060584 34063973
     [Google Scholar]
  100. MikulichA.V. PlavskiiV.Y. TretyakovaA.I. Potential of using medicinal plant extracts as photosensitizers for antimicrobial photodynamic therapy.Photochem. Photobiol.202410061833184710.1111/php.13935 38456366
     [Google Scholar]
  101. MansooriB. MohammadiA. DoustvandiA.M. Photodynamic therapy for cancer: Role of natural products.Photodiagn. Photodyn. Ther.20192639540410.1016/j.pdpdt.2019.04.033 31063860
     [Google Scholar]
  102. MarrelliM. MenichiniG. ProvenzanoE. ConfortiF. Applications of natural compounds in the photodynamic therapy of skin cancer.Curr. Med. Chem.201421121371139010.2174/092986732112140319094324 23531223
     [Google Scholar]
  103. MaiuoloJ. GliozziM. CarresiC. Nutraceuticals and cancer: Potential for natural polyphenols.Nutrients20211311383410.3390/nu13113834 34836091
     [Google Scholar]
  104. ZebA. Concept, mechanism, and applications of phenolic antioxidants in foods.J. Food Biochem.2020449e1339410.1111/jfbc.13394 32691460
     [Google Scholar]
  105. RahamanM.M. HossainR. Herrera-BravoJ. Natural antioxidants from some fruits, seeds, foods, natural products, and associated health benefits: An update.Food Sci. Nutr.20231141657167010.1002/fsn3.3217 37051367
     [Google Scholar]
  106. LeeJ. KimY. Quercetin composition having lipid lowering efficacy.Patent KR20100044974A2008
  107. OnoM. Compositions for treating diabetes or obesity.Patent WO20060742782006
  108. MastaloudisA. WoodS.M. BartlettM. HesterS. Nutritional compositions and associated methods.Patent US201800558022006
  109. CastelliS. SamaritaniG. FrungilloA. Oral composition for hyperlipidemia and cardio-vascolar risk factors control.Patent EP3406144A12018
  110. VeranoR.A. Ascortin.Patent PH1/2014/0003562014
  111. DimaC. AssadpourE. DimaS. JafariS.M. Bioavailability of nutraceuticals: Role of the food matrix, processing conditions, the gastrointestinal tract, and nanodelivery systems.Compr. Rev. Food Sci. Food Saf.202019395499410.1111/1541‑4337.12547 33331687
     [Google Scholar]
  112. GonçalvesR.F.S. MartinsJ.T. DuarteC.M.M. VicenteA.A. PinheiroA.C. Advances in nutraceutical delivery systems: From formulation design for bioavailability enhancement to efficacy and safety evaluation.Trends Food Sci. Technol.20187827029110.1016/j.tifs.2018.06.011
     [Google Scholar]
  113. LambertR. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin.WO Patent 20121222952012
  114. FreitasJ.C.C. De VieiraI.G.P. GuedesM.I.F. MoraisS.M. De MendesF.N.P. Desenvolvimento de produtos fitoterápicos adjuvantes no tratamento da leishmaniose visceral canina.BR Patent 102018009796A22020
  115. SiddiquiI. GrohD. DykhouseR. DaviesA. RehnborgC. StonebrookK. Composition and method for correcting a dietary phytochemical deficiency.WO Patent 20170850992017
  116. RaiszadehM.M. Compositions and methods for thromboembolism dissolution.WO Patent 20172057902020
  117. BusettiC. NiccolaiF. ZelaschiD. Composition for the prevention and/or treatment of allergy symptoms.WO Patent 20160467282016
  118. GrabowskiH.G. DiMasiJ.A. LongG. The roles of patents and research and development incentives in biopharmaceutical innovation.Health Aff.201534230231010.1377/hlthaff.2014.1047 25646111
     [Google Scholar]
  119. BelwalT. ChematF. VenskutonisP.R. Recent advances in scaling-up of non-conventional extraction techniques: Learning from successes and failures.Trends Analyt. Chem.202012711589510.1016/j.trac.2020.115895
     [Google Scholar]
  120. Pereira da SilvaA. GeraldesM. Díaz-LanzaA.M. KovacsI. CostaM.C. Family medicine physicians’ perception and attitudes of herbal substances use in greater Lisbon region.Phytomedicine20184711110.1016/j.phymed.2018.04.040 30166093
     [Google Scholar]
  121. SáK.M. LimaA.S. BandeiraM.A.M. AndriolaW.B. NojosaR.T. Avaliando o impacto da política brasileira de plantas medicinais e fitoterápicos na formação superior da área de saúde.Ibero American J Stud Edu20181331106113110.21723/riaee.v13.n3.2018.11160
     [Google Scholar]
  122. OzdemirA.A. BashanI. SelviH. Evaluation of physician candidates’ attitudes towards phytotherapy practices with a new scale.J. Herb. Med.20234010067110.1016/j.hermed.2023.100671
     [Google Scholar]
  123. SoaresT.J. TorkomianA.L.V. NaganoM.S. University regulations, regional development and technology transfer: The case of Brazil.Technol. Forecast. Soc. Change202015812012910.1016/j.techfore.2020.120129
     [Google Scholar]
  124. NetoB.N. Identifying technological trends and promoting strategies to boost innovation and technology transfer: A case study on the patent portfolio of brazilian public research institutions.J Aerosp Tech Manage20241610.1590/jatm.v16.1336
     [Google Scholar]
/content/journals/biot/10.2174/0118722083349741250325035323
Loading
Pharmacological Applications of Fava d'anta: A Patent Review
Recent Pat. Biotechnol. 20, 68 (2026); https://doi.org/10.2174/0118722083349741250325035323
/content/journals/biot/10.2174/0118722083349741250325035323
/content/journals/biot/10.2174/0118722083349741250325035323
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Dimorphandra; fava d'anta; innovation; intellectual property; patent indicators; rutin

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test